Comment Letters
Comment Letters
Biocom California is actively engaged in submitting comments to federal agencies and Congress on draft guidances and proposals. We monitor and engage in important legislative, regulatory and reimbursement matters on behalf of the California life science community. Click a topic on the right to review submitted letters.
drugs-biologics-letters
medical-device-letters
general-regulation-letters
reimbursement-letters
tax-letters
intellectual-property-letters
manufacturing-letters
appropriations-letters
Choose Your News
Biocom California distributes 7+ newsletters every month tailored to regional and focus area initiatives. Stay in touch and subscribe to the newsletters most relevant to you.